Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leuprorelin plus exemestane in premenopausal recurrent or metastatic breast cancer
ChiCTR-ONC-13003673Phase 4Completed
- Sponsor
- Key Laboratory of Carcinogenesis and Translational Research
- Start
- Oct 2013
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of leuprolide and exemestane in breast cancer, sponsored by Key Laboratory of Carcinogenesis and Translational Research. Primary endpoint: progression-free survival. Started Oct 2013; status: completed.
02
Drugs
leuprolideexemestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on ChiCTR-ONC-13003673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-13003673.